Tower Research Capital (TRC)’s Tevogen Inc. Common Stock TVGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.25K	Buy	941 +435	+86%	+$5.33K	﹤0.01%	4220
2025 Q4	$8.38K	Buy	506 +241	+91%	+$6.26K	﹤0.01%	3954
2025 Q3	$10.4K	Sell	265 -58	-18%	-$2.85K	﹤0.01%	3982
2025 Q2	$20.2K	Buy	323 +141	+77%	+$8.03K	﹤0.01%	3676
2025 Q1	$9.83K	Sell	182 -22	-11%	-$1.45K	﹤0.01%	3717
2024 Q4	$10.5K	Buy	204 +14	+7%	+$912	﹤0.01%	3797
2024 Q3	$3.49K	Buy	+190	New	+$5.55K	﹤0.01%	4838
2023 Q4	–	Sell	-9	Closed	-$4.89K	–	6209
2023 Q3	$4.89K	Buy	+9	New	+$4.86K	﹤0.01%	4796
2022 Q2	–	Sell	-8	Closed	-$4K	–	6592
2022 Q1	$4K	Buy	+8	New	+$3.98K	﹤0.01%	5269

Other funds holding TVGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Tower Research Capital (TRC)'s TVGN Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Tevogen Inc. Common Stock (TVGN) stake by 86% in Q1 2026, buying an estimated $5.33K and bringing the position to 941 shares worth $4.25K. The position accounts for ﹤0.01% of the portfolio, ranked #4220.

Tower Research Capital (TRC) first reported a position in TVGN in Q1 2022 and has held it in 9 quarters since. The position peaked at $20.2K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

Tower Research Capital (TRC) held 941 shares of Tevogen Inc. Common Stock worth $4.25K as of Q1 2026.
Tower Research Capital (TRC) bought 435 Tevogen Inc. Common Stock shares in Q1 2026, an estimated $5.33K.
Tevogen Inc. Common Stock made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4220 holding.
Tower Research Capital (TRC) first reported a position in Tevogen Inc. Common Stock in Q1 2022 and has held it in 9 quarters since.
Tower Research Capital (TRC)'s Tevogen Inc. Common Stock position peaked at $20.2K in Q2 2025.
30 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.